| Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study M Canonico, E Oger, G Plu-Bureau, J Conard, G Meyer, H Lévesque, ... Circulation 115 (7), 840-845, 2007 | 1013* | 2007 |
| Estrogen plus progestin and risk of venous thrombosis M Cushman, LH Kuller, R Prentice, RJ Rodabough, BM Psaty, RS Stafford, ... Jama 292 (13), 1573-1580, 2004 | 885 | 2004 |
| Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk PY Scarabin, E Oger, G Plu-Bureau The Lancet 362 (9382), 428-432, 2003 | 822 | 2003 |
| Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis M Canonico, G Plu-Bureau, GDO Lowe, PY Scarabin Bmj 336 (7655), 1227-1231, 2008 | 703 | 2008 |
| β Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM study I Behague, O Poirier, V Nicaud, A Evans, D Arveiler, G Luc, JP Cambou, ... Circulation 93 (3), 440-449, 1996 | 491 | 1996 |
| Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women: a randomized controlled trial PY Scarabin, M Alhenc-Gelas, G Plu-Bureau, P Taisne, R Agher, M Aiach Arteriosclerosis, thrombosis, and vascular biology 17 (11), 3071-3078, 1997 | 482 | 1997 |
| Fibrin (ogen) in cardiovascular disease: an update W Koenig Thrombosis and haemostasis 89 (04), 601-609, 2003 | 448 | 2003 |
| Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women S Vehkavaara, A Silveira, T Hakala-Ala-Pietilä, A Virkamäki, O Hovatta, ... Thrombosis and haemostasis 85 (04), 619-625, 2001 | 385 | 2001 |
| Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study M Canonico, A Fournier, L Carcaillon, V Olié, G Plu-Bureau, E Oger, ... Arteriosclerosis, thrombosis, and vascular biology 30 (2), 340-345, 2010 | 365 | 2010 |
| The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk … S Ye, FR Green, PY Scarabin, V Nicaud, L Bara, SJ Dawson, ... Thrombosis and haemostasis 74 (09), 837-841, 1995 | 322 | 1995 |
| Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction PY Scarabin, MF Aillaud, P Amouyel, A Evans, G Luc, J Ferrières, ... Thrombosis and haemostasis 80 (11), 749-756, 1998 | 299 | 1998 |
| Risk factors for early carotid atherosclerosis in middle-aged French women. C Bonithon-Kopp, PY Scarabin, A Taquet, PJ Touboul, A Malmejac, ... Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 11 (4), 966-972, 1991 | 285 | 1991 |
| Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis … B Simone, V De Stefano, E Leoncini, J Zacho, I Martinelli, J Emmerich, ... European journal of epidemiology 28, 621-647, 2013 | 239 | 2013 |
| Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging PJ Touboul, P Prati, PY Scarabin, V Adrai, E Thibout, P Ducimetière Journal of hypertension 10, S37-S42, 1992 | 238 | 1992 |
| Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe C Varas-Lorenzo, LA García-Rodríuez, C Cattaruzzi, MG Troncon, ... American journal of epidemiology 147 (4), 387-390, 1998 | 234 | 1998 |
| Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration C Straczek, E Oger, MB Yon de Jonage-Canonico, G Plu-Bureau, ... Circulation 112 (22), 3495-3500, 2005 | 232 | 2005 |
| Menopause-related changes in lipoproteins and some other cardiovascular risk factors C Bonithon-Kopp, PY Scarabin, B Darne, A Malmejac, L Guize International journal of epidemiology 19 (1), 42-48, 1990 | 224 | 1990 |
| Genetic approach to thrombophilia RM Bertina Thrombosis and haemostasis 86 (07), 92-103, 2001 | 216 | 2001 |
| Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial E Oger, M Alhenc-Gelas, K Lacut, MT Blouch, N Roudaut, V Kerlan, ... Arteriosclerosis, thrombosis, and vascular biology 23 (9), 1671-1676, 2003 | 209 | 2003 |
| Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein GDO Lowe, MN Upton, A Rumley, A McConnachie, DSJ O’Reilly, ... Thrombosis and haemostasis 86 (08), 550-556, 2001 | 208 | 2001 |
